Beta Bionics is targeting a valuation of up to $695 million in an upsized initial public offering, the insulin delivery device maker said on Tuesday.
Beta Bionics (BBNX), a developer of insulin delivery devices, has set terms for an upsized $165M initial public offering.
Google has just released the Android 16 Beta 1 update for supported Pixel devices. Here's an overview of what's new in this ...
OS users are set to get the ability to run two WhatsApp accounts, similar to Android users, but with the requirement of two ...
Android 16’s first public beta will start rolling out later today, bringing with it dynamic lockscreen notifications for ride ...
OpenSea, one of the largest multi-chain NFT market platforms, has launched the beta version of its upcoming upgraded NFT ...
TypeScript 5.8 introduces a number of optimizations that can both improve the time to build up a program, and also to update ...
Are you an adventurous AirPods user eager to explore the latest features before they're officially released? Beta firmware ...
Samsung's One UI 7 (debuting on the Galaxy S25) and Android 16 are bringing significant accessibility improvements for ...